Cardiol Therapeutics Inc. - Annual General Meeting Information

This filing provides details regarding the Annual General Meeting of Shareholders for Cardiol Therapeutics Inc., scheduled for June 24, 2026. Key agenda items include the receipt of audited financial statements for the fiscal year ended December 31, 2025, the election of directors, and the appointment of BDO Canada LLP as auditors. The meeting will be conducted online, and shareholders can access materials and participate via a webcast. The company is utilizing a notice-and-access mechanism for distributing meeting materials, which involves posting documents online rather than mailing paper copies to reduce costs and environmental impact. Information on how to appoint proxies, voting procedures, and details about the director nominees and their qualifications are also provided. The filing also includes a Compensation Discussion and Analysis section, outlining the corporation's policies and practices regarding the compensation of its named executive officers and directors.